Valneva makes U.S. regulatory submission for one-shot chikungunya vaccine
PARIS (Reuters) – Vaccines company Valneva said on Friday that
valneva
Valneva shares slump after COVID vaccine deal with EU falls apart
By Natalie Grover (Reuters) -Valneva lost nearly a fifth of
Vaccines company Valneva secures new financing with U.S firms Deerfield and OrbiMed
PARIS – French vaccines company Valneva, which is aiming to
Valneva targets 2022 revenue boost of up to 70% on COVID-19 vaccine
– French vaccine developer Valneva targets increasing its revenues year-on-year